RMD 1601
Alternative Names: RMD-1601Latest Information Update: 16 Jan 2024
At a glance
- Originator Remedium Bio
- Class Antirheumatics; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Rheumatoid arthritis
Most Recent Events
- 01 Dec 2023 Early research in Rheumatoid arthritis in USA (SC) prior to December 2023 (Remedium Bio pipeline, December 2023)